Alert to US Physicians: DHEA, Widely Used as an OTC Androgen Supplement, May Exacerbate COVID-19
December 2020
in “
Endocrine-related Cancer
”
New to dehydroepiandrosterone? There is a guide in the encyclopedia. Read the guide → 
Studysummary This article discusses the potential role of oral DHEA, available as a 'dietary supplement' in the US, in COVID-19 morbidity and mortality, calling for clinical trials to assess its safety.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discusses the potential risks of DHEA (Dehydroepiandrosterone), an over-the-counter androgen supplement widely used in the US, in exacerbating COVID-19. DHEA induces the ACE-2 receptor and TMPRS22, key to the virus's entry and infection process, and inhibits glucose-6-phosphate dehydrogenase (G6PD), making G6PD-deficient cells more susceptible to coronavirus infection. The document suggests that DHEA may contribute to SARS-CoV-2-induced vascular endothelialitis, leading to multi-organ inflammatory reactions, especially in diabetic patients and those with G6PD deficiency. The authors recommend considering the suspension of over-the-counter availability of DHEA unless its safety can be proven in placebo-controlled, randomized, double-blind clinical trials.
